메뉴 건너뛰기




Volumn 4, Issue 6, 2012, Pages

Lung cancer: Copayments and behavior following erlotinib formulary tier change

Author keywords

[No Author keywords available]

Indexed keywords

ERLOTINIB;

EID: 84869831990     PISSN: 19454481     EISSN: 21642494     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (4)

References (34)
  • 1
    • 84871055765 scopus 로고    scopus 로고
    • American Cancer Society, Published, Accessed Dec 21, 2011
    • American Cancer Society. What is non-small cell lung cancer. http://www.cancer.org/Cancer/LungCancer-Non-SmallCell/DetailedGuide/non-small-cell-lung-cancer-what-is-non-small-cell-lung-cancer. Published 2011. Accessed Dec 21, 2011.
    • (2011) What is Non-small Cell Lung Cancer
  • 2
    • 0036676214 scopus 로고    scopus 로고
    • Estimating health care costs related to cancer treatment from SEER-Medicare data
    • Brown ML, Riley G F, Schussler N, Etzioni R. Estimating health care costs related to cancer treatment from SEER-Medicare data. Med Care. 2002;40(8) (suppl):IV 104-117.
    • (2002) Med Care , vol.40 , Issue.8 SUPPL. 4 , pp. 104-117
    • Brown, M.L.1    Riley, G.F.2    Schussler, N.3    Etzioni, R.4
  • 3
    • 0003243818 scopus 로고    scopus 로고
    • The epidemiology of small cell lung carcinoma [abstract 1216]
    • Page N, Read W, Tierney R, et al. The epidemiology of small cell lung carcinoma [abstract 1216]. Proc Am Soc Clin Oncol. 2002;21:305.
    • (2002) Proc Am Soc Clin Oncol , vol.305 , pp. 21
    • Page, N.1    Read, W.2    Tierney, R.3
  • 4
    • 33745645399 scopus 로고    scopus 로고
    • Salvage therapy for advanced non-small cell lung cancer: Factors infl uencing treatment selection
    • Ramalingam S, Sandler AB. Salvage therapy for advanced non-small cell lung cancer: factors infl uencing treatment selection. Oncologist. 2006;11(6):655-665.
    • (2006) Oncologist , vol.11 , Issue.6 , pp. 655-665
    • Ramalingam, S.1    Sandler, A.B.2
  • 5
    • 10044284428 scopus 로고    scopus 로고
    • Treatment approaches in patients with advanced non-small cell lung cancer and poor performance status
    • Govindan R, Garfi eld DH. Treatment approaches in patients with advanced non-small cell lung cancer and poor performance status. Semin Oncol. 2004;31(6) (suppl 11):27-31.
    • (2004) Semin Oncol , vol.31 , Issue.6 SUPPL. 11 , pp. 27-31
    • Govindan, R.1    Garfield, D.H.2
  • 6
    • 34548620214 scopus 로고    scopus 로고
    • Pharmacy benefi t spending on oral chemotherapy drugs
    • Curtiss FR. Pharmacy benefi t spending on oral chemotherapy drugs. J Manag Care Pharm. 2006;12(7):570-577.
    • (2006) J Manag Care Pharm , vol.12 , Issue.7 , pp. 570-577
    • Curtiss, F.R.1
  • 7
    • 22044445517 scopus 로고    scopus 로고
    • National Cancer Institute of Canada Clinical Trials Group. Erlotinib in previously treated non-small-cell lung cancer
    • Shepherd FA, Rodrigues Pereira J, Ciuleanu T, et al; National Cancer Institute of Canada Clinical Trials Group. Erlotinib in previously treated non-small-cell lung cancer. N Engl J Med. 2005;353(2):123-132.
    • (2005) N Engl J Med , vol.353 , Issue.2 , pp. 123-132
    • Shepherd, F.A.1    Rodrigues, P.J.2    Ciuleanu, T.3
  • 8
    • 79955037760 scopus 로고    scopus 로고
    • Increase in oral cancer drugs raises thorny issues for oncology practices
    • Hede K. Increase in oral cancer drugs raises thorny issues for oncology practices. J Natl Cancer Inst. 2009;101(22):1534-1536.
    • (2009) J Natl Cancer Inst , vol.101 , Issue.22 , pp. 1534-1536
    • Hede, K.1
  • 9
    • 4344640030 scopus 로고    scopus 로고
    • Under-dosing study raises questions about ways to improve regimen adherence
    • Webb T. Under-dosing study raises questions about ways to improve regimen adherence. J Natl Cancer Inst. 2004;96(16):1201-1202.
    • (2004) J Natl Cancer Inst , vol.96 , Issue.16 , pp. 1201-1202
    • Webb, T.1
  • 10
    • 44249094168 scopus 로고    scopus 로고
    • Prescription compliance and persistency in chronic myelogenous leukemia (CML) and gastrointestinal stromal tumor (GIST) patients (Pts) on imatinib (IM): 2006 ASCP Annual Meeting Proceedings, part I
    • Tsang J, Rudychev I, Pescatore S. Prescription compliance and persistency in chronic myelogenous leukemia (CML) and gastrointestinal stromal tumor (GIST) patients (Pts) on imatinib (IM): 2006 ASCP Annual Meeting Proceedings, part I. J Clin Oncol. 2006;24(18S)(suppl):6119.
    • (2006) J Clin Oncol , vol.24 , Issue.18 SUPPL. , pp. 6119
    • Tsang, J.1    Rudychev, I.2    Pescatore, S.3
  • 11
    • 78349255323 scopus 로고    scopus 로고
    • Retrospective real-world comparison of medical visits, costs, and adherence between nilotinib and dasat-inib in chronic myeloid leukemia
    • Wu EQ, Guerin A, Yu A P, Bollu VK, Guo A, Griffi n JD. Retrospective real-world comparison of medical visits, costs, and adherence between nilotinib and dasat-inib in chronic myeloid leukemia. Curr Med Res Opin. 2010;26(12):2861-2869.
    • (2010) Curr Med Res Opin , vol.26 , Issue.12 , pp. 2861-2869
    • Wu, E.Q.1    Guerin, A.2    Yu, A.P.3    Bollu, V.K.4    Guo, A.5    Griffin, J.D.6
  • 12
    • 34249782019 scopus 로고    scopus 로고
    • Treatment interruptions and non-adherence with imatinib and associated healthcare costs: A retrospective analysis among managed care patients with chronic myelogenous leukaemia
    • Darkow T, Henk HJ, Thomas SK, et al. Treatment interruptions and non-adherence with imatinib and associated healthcare costs: a retrospective analysis among managed care patients with chronic myelogenous leukaemia. Pharmaco-economics. 2007;25(6):481-496.
    • (2007) Pharmaco-economics , vol.25 , Issue.6 , pp. 481-496
    • Darkow, T.1    Henk, H.J.2    Thomas, S.K.3
  • 13
    • 77954249679 scopus 로고    scopus 로고
    • Factors infl uencing cost-related nonadherence to medication in older adults: A conceptually based approach
    • Zivin K, Ratliff S, Heisler MM, Langa KM, Piette JD. Factors infl uencing cost-related nonadherence to medication in older adults: a conceptually based approach. Value Health. 2010;13(4):338-345.
    • (2010) Value Health , vol.13 , Issue.4 , pp. 338-345
    • Zivin, K.1    Ratliff, S.2    Heisler, M.M.3    Langa, K.M.4    Piette, J.D.5
  • 14
    • 30644474050 scopus 로고    scopus 로고
    • A conceptually based approach to understanding chronically ill patients' responses to medication cost pressures
    • Piette JD, Heisler M, Horne R, Caleb Alexander G. A conceptually based approach to understanding chronically ill patients' responses to medication cost pressures. Soc Sci Med. 2006;62(4):846-857.
    • (2006) Soc Sci Med , vol.62 , Issue.4 , pp. 846-857
    • Piette, J.D.1    Heisler, M.2    Horne, R.3    Caleb Alexander, G.4
  • 15
    • 78651093475 scopus 로고    scopus 로고
    • Predictors of non-adherence to aromatase inhibitors among commercially insured women with breast cancer
    • Sedjo RL, Devine S. Predictors of non-adherence to aromatase inhibitors among commercially insured women with breast cancer. Breast Cancer Res Treat. 2011;125(1):191-200.
    • (2011) Breast Cancer Res Treat , vol.125 , Issue.1 , pp. 191-200
    • Sedjo, R.L.1    Devine, S.2
  • 16
    • 79952115242 scopus 로고    scopus 로고
    • Nonadherence in patients with breast cancer receiving oral therapies
    • Moore S. Nonadherence in patients with breast cancer receiving oral therapies. Clin J Oncol Nurs. 2010;14(1):41-47.
    • (2010) Clin J Oncol Nurs , vol.14 , Issue.1 , pp. 41-47
    • Moore, S.1
  • 18
    • 77649221871 scopus 로고    scopus 로고
    • Healthcare resource utilization and costs associated with non-adherence to imatinib treatment in chronic myeloid leukemia patients
    • Wu EQ, Johnson S, Beaulieu N, et al. Healthcare resource utilization and costs associated with non-adherence to imatinib treatment in chronic myeloid leukemia patients. Curr Med Res Opin. 2010;26(1):61-69.
    • (2010) Curr Med Res Opin , vol.26 , Issue.1 , pp. 61-69
    • Wu, E.Q.1    Johnson, S.2    Beaulieu, N.3
  • 19
    • 56249122892 scopus 로고    scopus 로고
    • Behavioral and psychological predictors of chemotherapy adherence in patients with advanced non-small cell lung cancer
    • Greer JA, Pirl W F, Park ER, Lynch TJ, Temel JS. Behavioral and psychological predictors of chemotherapy adherence in patients with advanced non-small cell lung cancer. J Psychosom Res. 2008;65(6):549-552.
    • (2008) J Psychosom Res , vol.65 , Issue.6 , pp. 549-552
    • Greer, J.A.1    Pirl, W.F.2    Park, E.R.3    Lynch, T.J.4    Temel, J.S.5
  • 21
    • 22544468809 scopus 로고    scopus 로고
    • Estimating medication persistency using administrative claims data
    • Sikka R, Xia F, Aubert RE. Estimating medication persistency using administrative claims data. Am J Manag Care. 2005;11(7):449-457.
    • (2005) Am J Manag Care , vol.11 , Issue.7 , pp. 449-457
    • Sikka, R.1    Xia, F.2    Aubert, R.E.3
  • 22
    • 33748343357 scopus 로고    scopus 로고
    • Methods for evaluation of medication adherence and persistence using automated databases
    • Andrade SE, Kahler KH, Frech F, Chan KA. Methods for evaluation of medication adherence and persistence using automated databases. Pharmacoepidemiol Drug Saf. 2006;15(8):565-574.
    • (2006) Pharmacoepidemiol Drug Saf , vol.15 , Issue.8 , pp. 565-574
    • Andrade, S.E.1    Kahler, K.H.2    Frech, F.3    Chan, K.A.4
  • 23
    • 80052695744 scopus 로고    scopus 로고
    • Patient and plan characteristics affecting abandonment of oral oncolytic prescriptions
    • Streeter SB, Schwartzberg L, Husain N, Johnsrud M. Patient and plan characteristics affecting abandonment of oral oncolytic prescriptions. J Oncol Pract. 2011;7(3)(suppl):46s-51s.
    • (2011) J Oncol Pract , vol.7 , Issue.3 SUPPL.
    • Streeter, S.B.1    Schwartzberg, L.2    Husain, N.3    Johnsrud, M.4
  • 24
    • 79959761280 scopus 로고    scopus 로고
    • The use of erlotinib in daily practice: A study on adherence and patients' experiences
    • Timmers L, Boons CC, Mangnus D, et al. The use of erlotinib in daily practice: a study on adherence and patients' experiences. BMC Cancer. 2011;11:284.
    • (2011) BMC Cancer , vol.11 , pp. 284
    • Timmers, L.1    Boons, C.C.2    Mangnus, D.3
  • 25
    • 79955698843 scopus 로고    scopus 로고
    • Perspectives on adherence and persistence with oral medications for cancer treatment
    • Hohneker J, Shah-Mehta S, Brandt PS. Perspectives on adherence and persistence with oral medications for cancer treatment. J Oncol Pract. 2011;7(1): 65-67.
    • (2011) J Oncol Pract , vol.7 , Issue.1 , pp. 65-67
    • Hohneker, J.1    Shah-Mehta, S.2    Brandt, P.S.3
  • 26
    • 79960954634 scopus 로고    scopus 로고
    • Patient adherence to oral anticancer drugs: An emerging issue in modern oncology
    • Foulon V, Schöffski P, Wolter P. Patient adherence to oral anticancer drugs: an emerging issue in modern oncology. Acta Clin Belg. 2011;66(2):85-96.
    • (2011) Acta Clin Belg , vol.66 , Issue.2 , pp. 85-96
    • Foulon, V.1    Schöffski, P.2    Wolter, P.3
  • 27
  • 28
    • 0037441639 scopus 로고    scopus 로고
    • Nonadherence to adjuvant tamoxifen therapy in women with primary breast cancer
    • Partridge AH, Wang PS, Winer EP, Avorn J. Nonadherence to adjuvant tamoxifen therapy in women with primary breast cancer. J Clin Oncol. 2003;21(4): 602-606.
    • (2003) J Clin Oncol , vol.21 , Issue.4 , pp. 602-606
    • Partridge, A.H.1    Wang, P.S.2    Winer, E.P.3    Avorn, J.4
  • 29
    • 33847373003 scopus 로고    scopus 로고
    • Early discontinuation of tamoxifen: A lesson for oncologists
    • Barron TI, Connolly R, Bennett K, Feely J, Kennedy MJ. Early discontinuation of tamoxifen: a lesson for oncologists. Cancer. 2007;109(5):832-839.
    • (2007) Cancer , vol.109 , Issue.5 , pp. 832-839
    • Barron, T.I.1    Connolly, R.2    Bennett, K.3    Feely, J.4    Kennedy, M.J.5
  • 30
    • 0035863386 scopus 로고    scopus 로고
    • Adjuvant tamoxifen: Predictors of use, side effects, and discontinuation in older women
    • Demissie S, Silliman RA, Lash TL. Adjuvant tamoxifen: predictors of use, side effects, and discontinuation in older women. J Clin Oncol. 2001;19(2):322-328.
    • (2001) J Clin Oncol , vol.19 , Issue.2 , pp. 322-328
    • Demissie, S.1    Silliman, R.A.2    Lash, T.L.3
  • 31
    • 84869765947 scopus 로고    scopus 로고
    • Patient beliefs and tamoxifen discontinuance in older women with estrogen receptor-positive breast cancer
    • Fink AK, Gurwitz J, Rakowski W, Guadagnoli E, Silliman RA. Patient beliefs and tamoxifen discontinuance in older women with estrogen receptor-positive breast cancer. J Clin Oncol. 2004;109(5):832-839.
    • (2004) J Clin Oncol , vol.109 , Issue.5 , pp. 832-839
    • Fink, A.K.1    Gurwitz, J.2    Rakowski, W.3    Guadagnoli, E.4    Silliman, R.A.5
  • 32
    • 70350728600 scopus 로고    scopus 로고
    • Cost-related medication nonadherence after implementation of Medicare Part D, 2006-2007
    • Madden JM, Graves AJ, Ross-Degnan D, Briesacher BA, Soumerai SB. Cost-related medication nonadherence after implementation of Medicare Part D, 2006-2007. JAMA. 2009;302(16):1755-1756.
    • (2009) JAMA , vol.302 , Issue.16 , pp. 1755-1756
    • Madden, J.M.1    Graves, A.J.2    Ross-Degnan, D.3    Briesacher, B.A.4    Soumerai, S.B.5
  • 33
    • 79955678058 scopus 로고    scopus 로고
    • Medication safety of fi ve oral chemotherapies: A proactive risk assessment
    • Weingart SN, Spencer J, Bula D, et al. Medication safety of fi ve oral chemotherapies: a proactive risk assessment. J Oncol Pract. 2011;7(1):2-6.
    • (2011) J Oncol Pract , vol.7 , Issue.1 , pp. 2-6
    • Weingart, S.N.1    Spencer, J.2    Bula, D.3
  • 34
    • 78651071074 scopus 로고    scopus 로고
    • Approval summary: Erlotinib maintenance therapy of advanced/metastatic non-small cell lung cancer (NSCLC)
    • E3
    • Cohen MH, Johnson JR, Chattopadhyat S, et al. Approval summary: erlotinib maintenance therapy of advanced/metastatic non-small cell lung cancer (NSCLC). Oncologist. 2010;15(3):1344-1351. E3
    • (2010) Oncologist , vol.15 , Issue.3 , pp. 1344-1351
    • Cohen, M.H.1    Johnson, J.R.2    Chattopadhyat, S.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.